| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $243.6M | +1.0% | +8.2% |
| Cost of Revenue | $18.9M | +2.3% | +32.0% |
| Gross Profit | $224.6M | +0.9% | +12.5% |
| R&D Expense | $37.7M | — | +3.9% |
| SG&A Expense | $26.5M | — | -1.1% |
| Operating Income | $40.1M | — | -12.4% |
| Pre-tax Income | $41.1M | — | -15.3% |
| Income Tax | $8.9M | — | -6.2% |
| Net Income | $32.2M | -35.3% | -17.5% |
| EPS (Basic) | $0.34 | -34.6% | -10.5% |
| EPS (Diluted) | $0.34 | -33.3% | -8.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $72.0M | -62.2% | -58.3% |
| Accounts Receivable | $44.6M | +6.3% | +9.5% |
| Current Assets | $161.9M | -42.8% | -35.8% |
| Total Assets | $519.6M | -21.5% | -24.6% |
| Current Liabilities | $98.0M | -2.6% | +3.6% |
| Long-term Debt | $0 |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $69.8M | — | +2.9% |
| Capital Expenditures | $391K | — | -82.5% |
| Investing Cash Flow | -$6.7M | — | +12.3% |
| Financing Cash Flow | -$181.0M | — | +5.5% |
| Free Cash Flow | $69.5M | — | +5.8% |
| — |
| Total Liabilities | $282.5M | -1.8% | -1.6% |
| Stockholders' Equity | $237.1M | -36.6% | -41.0% |